Mauna Kea Technologies

Report Publication Announcement • Dec 21, 2015

Mauna Kea Technologies Announces its 2016 Financial Calendar

PARIS, December 21, 2015 /PRNewswire/ --

Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, announced today its schedule for the publication of financial information for 2016.

Event                           Date \*
2015 Full-Year Sales            January 26, 2016
2015 Full-Year Results          March 24, 2016
2016 First-Quarter Sales        April 27, 2016
2016 First-Half Sales           July 27, 2016
2016 First-Half Results         September 21, 2016
2016 Third-Quarter Sales        November 2, 2016

* Subject to modification. Press releases are published after market closes.

About Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company focused on protecting patients' lives while enabling physicians and surgeons to make better decisions thanks to direct visualization at the cellular level. The Company's flagship product, Cellvizio, has received clearance to sell a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico. For more information on Mauna Kea Technologies, visit www.maunakeatech.com

Mauna Kea Technologies

Investors relations US

Sebastien Cadet

Global Marketing Director and OEM Leader

sebastienc@maunakeatech.com

NewCap.

Investor Relations Europe

Florent Alba

Tel: +33 (0) 1 44 71 94 94

maunakea@newcap.fr

This is a disclosure announcement from PR Newswire.